Loading...
Printed on 7/21/2026
For informational purposes only. This is not medical advice.
The Short Blessed Test is a rapid weighted cognitive screening instrument derived from orientation, memory, and concentration tasks. It is widely used for quick bedside triage of possible cognitive impairment and dementia-range concern.
Formula: SBT weighted total score range 0-28 (higher indicates greater impairment signal).
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
The Short Blessed Test (also called Blessed Orientation-Memory-Concentration test or BOMC) consists of six items assessed at the bedside: (1) What year is it? (2) What month is it? (3) What time is it (within 1 hour)? (4) Count backward from 20 to 1. (5) Say the months in reverse order (December, November, October...). (6) Repeat back a short phrase (e.g., 'John Brown, 42 Market Street, Chicago') asked at the beginning of the test and recalled at the end. Each item has a specific error-weighting factor: year (4), month (3), time (3), counting backward (2), months reversed (2), recall phrase (2). These weights reflect the relative discriminating power of each item for identifying dementia.
For each item, count the number of errors and multiply by the item-specific weighting factor. For orientation items (year, month, time), score as 0 if correct or the weighted value if wrong. For performance items (counting backward, months in reverse, phrase recall), partial credit applies: full errors are multiplied by the weight. Sum all weighted error scores for the SBT total. Range 0 to 28. Note that unlike most cognitive tests where higher scores are better, in the SBT a higher score indicates MORE errors — which means WORSE cognitive performance. This reverse directionality should be explicitly communicated when reporting.
Apply the validated SBT interpretation bands: 0 to 4 = normal cognitive function; 5 to 9 = questionable impairment requiring further evaluation; 10 to 28 = impairment consistent with dementia-range cognitive concern. A score of 10 or above is the threshold commonly used to flag significant impairment requiring further assessment. Serial SBT measurement documents cognitive change over time — a rising SBT score indicates worsening cognitive function. The SBT is a screening tool and abnormal scores should trigger comprehensive cognitive and functional assessment rather than direct dementia diagnosis.
Hospitalists, primary care physicians, emergency physicians, geriatricians
The SBT takes 3 to 5 minutes to administer, requires no special equipment or forms, and can be performed entirely verbally at the bedside. This makes it one of the most practical brief cognitive screens for busy acute care, primary care, and geriatric settings where longer tests are impractical. The SBT's focus on orientation, concentration, and short-term memory covers the cognitive domains most affected by Alzheimer's disease and most relevant to clinical decision-making about cognitive impairment. Its weighted scoring system differentiates severity better than simple error counts.
Admitting nurses, hospitalists, geriatric liaison teams
SBT is widely used as a routine cognitive baseline on hospital admission in older adults, particularly in geriatric and orthopedic wards. Documenting a baseline SBT at admission establishes the cognitive reference point for detecting subsequent delirium superimposed on dementia, comparing cognitive status at discharge versus admission, and informing post-discharge care needs. A SBT score of 10 or above at admission identifies patients who benefit from enhanced fall prevention, simplified medication management, increased nursing supervision, and early geriatric assessment.
Memory clinic physicians, geriatric psychiatrists, neurologists
The SBT's simplicity and brevity make it practical for serial cognitive monitoring in memory clinic follow-up visits, where longer test administration is not feasible at every appointment. A rising SBT score over serial assessments documents cognitive deterioration that supports Alzheimer's disease progression, triggers medication review, and informs staging decisions. The SBT correlates reasonably well with MMSE and MoCA scores, allowing rough cross-tool comparison. In longitudinal research, the SBT has been used as a simple cognitive outcome measure that is feasible for non-specialist administration.
Long-term care nurses, nursing home physicians, care home managers
The SBT is practical for nursing home and long-term care cognitive monitoring because it requires no paper forms, no specialized training, and can be completed in under 5 minutes by nursing staff. Regular SBT monitoring in long-term care residents detects acute cognitive deterioration — typically delirium superimposed on baseline dementia — that warrants clinical assessment and investigation for precipitating causes (infection, medication change, metabolic disturbance). Serial SBT results provide objective documentation of cognitive trajectory for care plan updates and family communication.
Neuropathologists, dementia researchers, clinical researchers
The Short Blessed Test was originally developed in the context of neuropathological research correlating antemortem clinical performance with postmortem Alzheimer's brain pathology (plaques and tangles) in the landmark Blessed, Tomlinson, and Roth studies from the 1960s to 1980s. This gives the SBT historical and scientific significance as a validated correlate of Alzheimer's neuropathology — one of the earliest cognitive measures used to establish the clinicopathological basis of Alzheimer's disease. SBT scores correlate with Alzheimer's pathology burden, providing scientific validity beyond clinical utility.
The SBT scores errors — unlike most cognitive tests where higher scores are better, a higher SBT total means more errors and worse cognitive performance. Always communicate this directionality explicitly when reporting or discussing SBT results: 'SBT score of 12 — this indicates impairment' not 'SBT score of 12 — this is high.' This reverse directionality is a common source of clinical communication errors.
The SBT's item weights are not arbitrary — they were empirically derived to maximize discrimination between cognitively normal older adults and those with dementia. The year orientation item (weight 4) is the highest-weighted because year orientation is the most specifically impaired in Alzheimer's dementia compared to normal aging. The phrase recall item (weight 2) provides a short-term memory measure. Understanding the weighting helps interpret which type of error is most clinically significant.
The phrase recall item requires presenting the phrase (e.g., 'John Brown, 42 Market Street, Chicago') at the BEGINNING of the SBT administration, before administering the other items. The patient is asked to recall it at the END of the test after the other items (functioning as a 3 to 5 minute delayed recall). Forgetting to present the phrase at the beginning is a common administration error that invalidates the recall item. Note the phrase used in documentation.
The months in reverse item (December, November, October...) primarily tests sustained concentration and cognitive flexibility rather than memory, similar to the Serial 7s or WORLD backward items in other cognitive screens. A patient who recites months forward without error but fails the reverse task has a selective concentration/processing speed deficit that is highly sensitive to early cognitive decline. Always attempt this item even in patients who appear mildly impaired.
The time orientation item scores as correct if the patient's answer is within 1 hour of the actual current time. An answer exactly 1 hour off scores as correct; an answer more than 1 hour off scores as an error. This allows for patients who know the approximate time of day but not the exact minute. Always check the actual time before administering and document the time of testing. A patient who confidently states an incorrect hour that differs by more than 1 hour is demonstrating a meaningful orientation error.
The intermediate score zone (5 to 9) represents questionable impairment that should not be dismissed. Many patients in this range have early dementia or MCI that warrants full cognitive and functional assessment. Do not reassure patients with scores in this range — instead, document the score, plan a comprehensive follow-up cognitive evaluation (MoCA, neuropsychological testing), and assess functional impairment with informant-based tools like [Pfeffer FAQ](/tools/pfeffer-faq).
Acute medical illness, delirium, metabolic disturbances, and sedating medications can substantially elevate SBT scores in patients who are cognitively normal or only mildly impaired at baseline. An SBT of 15 in a patient with active pneumonia and delirium does not reflect their true cognitive baseline. Always assess SBT results in the context of current medical status and, when possible, repeat after acute illness resolution to obtain a more accurate baseline cognitive measurement.
The SBT assesses cognitive performance but not functional impact. An SBT score of 8 (questionable impairment) has very different clinical implications depending on whether the patient is functionally independent in IADLs (MCI profile) or dependent in multiple IADLs (dementia profile). Always supplement the SBT with an informant-based functional assessment such as the [Pfeffer FAQ](/tools/pfeffer-faq) or [Lawton IADL](/tools/lawton-iadl) to complete the cognitive evaluation.
The short orientation-memory-concentration format has long-standing validation as a brief screen for cognitive impairment in older adults.
Higher SBT totals indicate greater cognitive impairment signal and support further structured assessment.
Use as a rapid first-pass screen when time constraints limit longer neurocognitive testing.
Scores can be affected by education, language, sensory deficits, and acute illness; SBT alone is not diagnostic.
For related assessments, see 6CIT, AD8 Screen and IQCODE-16.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Rapid cognitive screening with the Six-Item Cognitive Impairment Test (6CIT), weighted score range 0-28.
OpenGeriatricsScreen for cognitive impairment using the 8-item AD8 informant interview (score 0-8).
OpenGeriatricsEstimate informant-reported cognitive decline using the short 16-item IQCODE mean score.
OpenMental HealthInterpret Montreal Cognitive Assessment (MoCA) scores. The leading cognitive screening tool for mild cognitive impairment and dementia.
Open